SH3KBP1 and breast carcinoma: We used siRNA targeting of CIN85 and achieved over 70% reduction of CIN85 mRNA in transfected MDA-MB-231 cells and another breast cancer cell line MDA-MB-435, compared to parental cells (Fig.6A and C).